Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
IRIS-ROTA
1 other identifier
observational
500
1 country
8
Brief Summary
This study evaluates the effectiveness and safety rotational atherectomy in routine clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2018
Longer than P75 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2018
CompletedFirst Posted
Study publicly available on registry
February 9, 2018
CompletedStudy Start
First participant enrolled
September 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2034
January 2, 2026
December 1, 2025
11.3 years
February 5, 2018
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Target vessel failure (TVF)
Target vessel failure (TVF) composite of death, nonfatal myocardial infarction (MI), or ischemic-driven Target Vessel Revascularization (TVR) at 12 months after the procedure.
1 year
Secondary Outcomes (10)
All death
1-,6-, and 12-months, and 3-,5-years
Cardiac death
1-,6-, and 12-months, and 3-,5-years
Myocardial infarction
1-,6-, and 12-months, and 3-,5-years
Composite of death or myocardial infarction
1-,6-, and 12-months, and 3-,5-years
Composite of cardiac death or myocardial infarction
1-,6-, and 12-months, and 3-,5-years
- +5 more secondary outcomes
Study Arms (1)
Coronary disease
Interventions
Percutaneous coronary intervention with rotational atherectomy
Eligibility Criteria
Consecutive percutaneous coronary intervention patients receiving rotational atherectomy
You may qualify if:
- Patients ≥ 19 years old
- Patients who received rotational atherectomy
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
You may not qualify if:
- Life expectancy \<1y
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seung-Jung Parklead
- CardioVascular Research Foundation, Koreacollaborator
Study Sites (8)
Soon Chun Hyang University Hospital Bucheon
Bucheon-si, South Korea
Daegu Catholic University Medical Center
Daegu, South Korea
Chungnam National University Hospital
Daejeon, South Korea
The Catholic University of Korea, Daejeon ST. Mary's Hospital
Daejeon, South Korea
Chonnam National University Hospital
Gwangju, South Korea
Inje University Pusan Paik Hospital
Pusan, South Korea
Bundang CHA Hospital
Seongnam, South Korea
Asan Medical Center
Seoul, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Division of Cardiology
Study Record Dates
First Submitted
February 5, 2018
First Posted
February 9, 2018
Study Start
September 4, 2018
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2034
Last Updated
January 2, 2026
Record last verified: 2025-12